Literature DB >> 11534831

The lacZ gene transfer into L929 cells and [14C]-DNA tissue distribution following intraperitoneal administration of new pH-sensitive lipoplexes in mice.

Y V Sviridov1, R I Zhdanov, O V Podobed, T A Tsvetkova, I Konstantinov, E V Bogdanenko.   

Abstract

The efficacy of lacZ gene transfer into the L929 cell line and a local [l4C]-DNA delivery in male NMRI mice (10-12 weeks old), were studied using new pH-sensitive liposomes, containing phosphatidylcholine/glycyrrhizin (PC/GL) or alpha-tocopherol ester of succinic acid (PC/TSA). The reporter gene (pQE-LacZ plasmid) was transferred into L929 cells using corresponding lipoplexes, 0.5% of cells being transfected. Tissue distribution of Gasserian ganglion neurinoma cell [14C]-DNA fragments and corresponding PC/GL and PC/TSA lipoplexes, were examined following intraperitoneal administration of a 24 h postdose. The [14C]-DNA itself was not detected in any organs at a 1.5 h postdose. The use of PC/GL or PC/TSA lipoplexes considerably changed the biodistribution of [14C]-DNA in mice tissues. The maximal content of [14C]-DNA for both types of lipoplexes was observed in the intestine (50% dose equiv./g) and the spleen (30% dose equiv./g). The content of [14C]-DNA in liver and kidneys was equal to 4 and 10% for liver and kidneys in the case of PC/GL-lipoplexes, and 15 and 6%, for PC/TSA, respectively. Thus, the tropicity for PC/GL-lipoplexes to liver was not detected under i.p. administration.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11534831

Source DB:  PubMed          Journal:  Cytobios        ISSN: 0011-4529


  3 in total

1.  A glycolipid containing a lactose residue: a novel agent for targeted DNA delivery for the purpose of genetic therapy.

Authors:  E V Bogdanenko; R I Zhdanov; Yu L Sebyakin; T V Zarubina; V V Vlasov
Journal:  Dokl Biochem Biophys       Date:  2005 Mar-Apr       Impact factor: 0.788

Review 2.  DNA-based therapeutics and DNA delivery systems: a comprehensive review.

Authors:  Siddhesh D Patil; David G Rhodes; Diane J Burgess
Journal:  AAPS J       Date:  2005-04-08       Impact factor: 4.009

3.  DNA as therapeutics; an update.

Authors:  P Saraswat; R R Soni; A Bhandari; B P Nagori
Journal:  Indian J Pharm Sci       Date:  2009-09       Impact factor: 0.975

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.